BioInvent International AB (BOVNF)
3.289
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
BioInvent International Total Assets (Quarterly) : 56.16M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 56.16M |
| December 31, 2025 | 72.81M |
| September 30, 2025 | 83.55M |
| June 30, 2025 | 96.18M |
| March 31, 2025 | 85.89M |
| December 31, 2024 | 89.53M |
| September 30, 2024 | 107.28M |
| June 30, 2024 | 113.22M |
| March 31, 2024 | 124.26M |
| December 31, 2023 | 138.94M |
| September 30, 2023 | 136.51M |
| June 30, 2023 | 148.01M |
| March 31, 2023 | 159.74M |
| December 31, 2022 | 164.33M |
| September 30, 2022 | 158.15M |
| June 30, 2022 | 151.92M |
| March 31, 2022 | 148.16M |
| December 31, 2021 | 159.86M |
| September 30, 2021 | 173.76M |
| June 30, 2021 | 185.71M |
| March 31, 2021 | 186.61M |
| December 31, 2020 | 97.73M |
| September 30, 2020 | 78.61M |
| June 30, 2020 | 26.92M |
| March 31, 2020 | 19.61M |
| Date | Value |
|---|---|
| December 31, 2019 | 24.15M |
| September 30, 2019 | 27.85M |
| June 30, 2019 | 34.13M |
| March 31, 2019 | 15.23M |
| December 31, 2018 | 13.58M |
| September 30, 2018 | 16.28M |
| June 30, 2018 | 20.63M |
| March 31, 2018 | 27.05M |
| December 31, 2017 | 20.77M |
| September 30, 2017 | 23.76M |
| June 30, 2017 | 26.11M |
| March 31, 2017 | 26.70M |
| December 31, 2016 | 30.41M |
| September 30, 2016 | 25.36M |
| June 30, 2016 | 28.68M |
| March 31, 2016 | 7.165M |
| December 31, 2015 | 6.458M |
| September 30, 2015 | 8.25M |
| June 30, 2015 | 11.01M |
| March 31, 2015 | 5.723M |
| December 31, 2014 | 9.467M |
| September 30, 2014 | 13.99M |
| June 30, 2014 | 17.84M |
| March 31, 2014 | 8.366M |
| December 31, 2013 | 12.68M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| BONESUPPORT HOLDING AB | 117.45M |
| Hansa Biopharma AB | 122.00M |
| BioArctic AB | 281.25M |
| Swedish Orphan Biovitrum AB | 8.530B |
| Diamyd Medical AB | 28.11M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 10.06M |
| Shareholders Equity (Quarterly) | 46.09M |
| Debt to Equity Ratio | 0.0142 |
| Current Ratio | 5.316 |
| Net Debt Paydown Yield | 0.08% |